ArticleCellular & molecular immunology2026

CRISPRa screen unveils noncanonical NF-κB to boost the antitumor activity of TCR-based CAR-T cells.

Hanyang Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.